Chief medical officer, NeuroPace, and clinical professor of neurology, Stanford University

Martha Morrell, MD

“This is the very first time, of course, that physicians have had access to this type of quantitative brain data in individuals who are walking about living their normal lives. We've really relied on patients being able to tell us how they are doing, and that's difficult…The nSight platform shows what has occurred according to times of day, and days over the week, and weeks over the month.”

Recent announcement of the nSight Platform from NeuroPace coincides with new advancements in telehealth, in accordance with the effort to increase access to healthcare following the COVID-19 pandemic. Martha Morrell, MD, chief medical officer of NeuroPace, clinical professor of neurology, Stanford University, spoke with 

 on the impact of the nSight Platform, which works alongside the company’s RNS System to track seizure-related outcomes for patients with drug-resistant focal epilepsy. 

Morrell outlined the related data management systems and the platform’s integrated ability to track patient data 24 hours per day. The nSight platform serves as a way to “synthesize and integrate” the large amount of data collected, allowing providers to view individual patient trends and enact appropriate interventions via the RNS System, medication, or behavior changes. According to Morrell, tracking patient progress and/or response to medications is also assisted by the nSight Platform, in that it provides an additional source of information to eventually improve patient outcomes. 

REFERENCE

NeuroPace launches nSight Platform and partnership with Seizure Tracker™ to provide doctors with personalized information about their patients’ seizure burden. August 4, 2021. Accessed August 25, 2021. https://www.businesswire.com/news/home/20210804005401/en/NeuroPace-Launches-nSight-Platform-and-Partnership-with-Seizure-Tracker%E2%84%A2-to-Provide-Doctors-With-Personalized-Information-About-Their-Patients%E2%80%99-Seizure-Burden

Videos

The chief medical officer of NeuroPace discussed the data provided by the company’s new nSight Platform for seizure-related outcome tracking, which also offers improved potential for patient monitoring.  

Patient and Provider Benefits With the nSight Platform: Martha Morrell, MD 

“What I want to make sure that neurologists understand, which they already do, is that we are moving into an era of data science—we all are—in all aspects of our life, but the RNS System is an example of one of the new therapies that are acquiring great amounts of data. The challenge for us is to understand how to apply data analytics so that we have information that we can comprehend, that we can condense, and that we can act upon.”

NeuroPace recently announced the launch of its nSight Platform, which works in tandem with its RNS System, a direct brain responsive neurostimulator, to assist with treatment of patients with medically intractable focal onset seizures. The nSight platform facilitates the transfer and storage of the data collected from the RNS System, providing a consolidated location for providers to review patient reports. 

Martha Morrell, MD, chief medical officer, NeuroPace, and clinical professor of neurology, Stanford University, spoke with 

 on the device, outlining its capabilities and key takeaways for clinicians. The nSight Platform and the RNS System, as well as Seizure Tracker, with which NeuroPace has partnered, aims to ease seizure burden for patients with drug-resistant focal epilepsy by logging seizure activity and frequency. The online portal is intended to better inform patient care by providing information quickly and easily to providers, while also opening the line of communication with patients. 

Discussing the new platform, the chief medical officer of NeuroPace spoke on the potential to open and streamline patient-provider communication with the company’s nSight Platform and its RNS system.  

Martha Morrell, MD

Articles

Patient and Provider Benefits With the nSight Platform: Martha Morrell, MD

nSight Platform for Remote Seizure Burden, Activity Tracking: Martha Morrell, MD

Latest News